Aprea Therapeutics, Inc. (APRE)

Aprea Therapeutics Statistics

Total Valuation

APRE has a market cap or net worth of $8.24 million. The enterprise value is -$14.61 million.

Market Cap	8.24M
Enterprise Value	-14.61M

Important Dates

The next estimated earnings date is Tuesday, May 13, 2025, before market open.

Earnings Date	May 13, 2025
Ex-Dividend Date	n/a

Share Statistics

APRE has 5.49 million shares outstanding. The number of shares has increased by 52.31% in one year.

Current Share Class	5.49M
Shares Outstanding	5.49M
Shares Change (YoY)	+52.31%
Shares Change (QoQ)	+0.25%
Owned by Insiders (%)	11.86%
Owned by Institutions (%)	26.72%
Float	4.02M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	5.50
Forward PS	n/a
PB Ratio	0.43
P/TBV Ratio	0.43
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 7.01

Current Ratio	7.01
Quick Ratio	6.80
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -66.65% and return on invested capital (ROIC) is -46.03%.

Return on Equity (ROE)	-66.65%
Return on Assets (ROA)	-38.39%
Return on Invested Capital (ROIC)	-46.03%
Return on Capital Employed (ROCE)	-69.45%
Revenue Per Employee	$187,823
Profits Per Employee	-$1.62M
Employee Count	8
Asset Turnover	0.06
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -70.70% in the last 52 weeks. The beta is 1.62, so APRE's price volatility has been higher than the market average.

Beta (5Y)	1.62
52-Week Price Change	-70.70%
50-Day Moving Average	2.27
200-Day Moving Average	3.19
Relative Strength Index (RSI)	27.08
Average Volume (20 Days)	29,438

Short Selling Information

The latest short interest is 59,744, so 1.09% of the outstanding shares have been sold short.

Short Interest	59,744
Short Previous Month	55,649
Short % of Shares Out	1.09%
Short % of Float	1.48%
Short Ratio (days to cover)	2.78

Income Statement

In the last 12 months, APRE had revenue of $1.50 million and -$12.96 million in losses. Loss per share was -$2.35.

Revenue	1.50M
Gross Profit	-7.86M
Operating Income	-14.32M
Pretax Income	-12.72M
Net Income	-12.96M
EBITDA	-14.30M
EBIT	-14.32M
Loss Per Share	-$2.35

Balance Sheet

The company has $22.85 million in cash and n/a in debt, giving a net cash position of $22.85 million or $4.16 per share.

Cash & Cash Equivalents	22.85M
Total Debt	n/a
Net Cash	22.85M
Net Cash Per Share	$4.16
Equity (Book Value)	20.62M
Book Value Per Share	3.52
Working Capital	20.22M

Cash Flow

In the last 12 months, operating cash flow was -$13.56 million and capital expenditures -$15,478, giving a free cash flow of -$13.57 million.

Operating Cash Flow	-13.56M
Capital Expenditures	-15,478
Free Cash Flow	-13.57M
FCF Per Share	-$2.47

Margins

Gross Margin	n/a
Operating Margin	-953.00%
Pretax Margin	-862.43%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

APRE does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-52.31%
Shareholder Yield	-52.31%
Earnings Yield	-157.31%
FCF Yield	-164.75%

Analyst Forecast

The average price target for APRE is $15.50, which is 933.33% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$15.50
Price Target Difference	933.33%
Analyst Consensus	Strong Buy
Analyst Count	2
Revenue Growth Forecast (5Y)	140.25%
EPS Growth Forecast (5Y)	n/a

Stock Splits

The last stock split was on February 13, 2023. It was a reverse split with a ratio of 0.05:1.

Last Split Date	Feb 13, 2023
Split Type	Reverse
Split Ratio	0.05:1

Scores

APRE has an Altman Z-Score of -15.67 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-15.67
Piotroski F-Score	3